Ursula Wiedermann

Summary

Affiliation: Medical University of Vienna
Country: Austria

Publications

  1. ncbi Hitting the mucosal road in tolerance induction
    Ursula Wiedermann
    Department of Specific Prophylaxis and Tropical Medicine, Center for Physiology and Pathophysiology, Medical University Vienna, Vienna, Austria
    Nestle Nutr Workshop Ser Pediatr Program 64:63-72; discussion 72-74, 251-7. 2009
  2. ncbi Vaccines against traveler's diarrhoea and rotavirus disease - a review
    Ursula Wiedermann
    Department of Specific Prophylaxis and Tropical Medicine, Center for Physiology and Pathophysiology, Medical University of Vienna, Vienna, Austria
    Wien Klin Wochenschr 118:2-8. 2006
  3. ncbi A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study
    Ursula Wiedermann
    Institute of Specific Prophylaxis and Tropical Medicine, Medical University of Vienna, Kinderspitalgasse 15, 1090 Vienna, Austria
    Breast Cancer Res Treat 119:673-83. 2010
  4. ncbi Prophylaxis and therapy of allergy by mucosal tolerance induction with recombinant allergens or allergen constructs
    Ursula Wiedermann
    Department of Specific Prophylaxis and Tropical Medicine at the Center for Physiology and Pathophysiology, Medical University of Vienna, Vienna, Austria
    Curr Drug Targets Inflamm Allergy 4:577-83. 2005
  5. ncbi [Adjuvants and additives in vaccines--medical relevance]
    Ursula Wiedermann-Schmidt
    Institut für Spezifische Prophylaxe und Tropenmedizin, Zentrum für Physiologie und Pathophysiologie, Medizinische Universität Wien, Wien, Austria
    Wien Klin Wochenschr 117:510-9. 2005
  6. ncbi Tick borne encephalitis TBE--vaccination in non-endemic countries
    Ursula Wiedermann
    Institute of Specific Prophylaxis and Tropical Medicine, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Kinderspitalgasse 15, A 1090 Vienna, Austria
    Travel Med Infect Dis 8:251-6. 2010
  7. ncbi Vaccination with a human high molecular weight melanoma-associated antigen mimotope induces a humoral response inhibiting melanoma cell growth in vitro
    Stefan Wagner
    Bio Life Science, Vienna, Austria
    J Immunol 174:976-82. 2005
  8. ncbi Delayed tumor onset and reduced tumor growth progression after immunization with a Her-2/neu multi-peptide vaccine and IL-12 in c-neu transgenic mice
    Stefan Wagner
    Department of Pathophysiology, Center for Physiology and Pathophysiology, Medical University of Vienna, Vienna, Austria
    Breast Cancer Res Treat 106:29-38. 2007
  9. ncbi A hybrid molecule resembling the epitope spectrum of grass pollen for allergy vaccination
    Birgit Linhart
    Cenetr of Physiology and Pathophysiology, Department of Pathophysiology, Medical University of Vienna, Austria
    J Allergy Clin Immunol 115:1010-6. 2005
  10. ncbi Epitope-specific antibody response to Mel-CAM induced by mimotope immunization
    Christine Hafner
    Department of Dermatology, Division of General Dermatology, Medical University of Vienna, Austria
    J Invest Dermatol 124:125-31. 2005

Detail Information

Publications37

  1. ncbi Hitting the mucosal road in tolerance induction
    Ursula Wiedermann
    Department of Specific Prophylaxis and Tropical Medicine, Center for Physiology and Pathophysiology, Medical University Vienna, Vienna, Austria
    Nestle Nutr Workshop Ser Pediatr Program 64:63-72; discussion 72-74, 251-7. 2009
    ..An overview of our recent studies will be given...
  2. ncbi Vaccines against traveler's diarrhoea and rotavirus disease - a review
    Ursula Wiedermann
    Department of Specific Prophylaxis and Tropical Medicine, Center for Physiology and Pathophysiology, Medical University of Vienna, Vienna, Austria
    Wien Klin Wochenschr 118:2-8. 2006
    ..With respect to increasing travel habits with infants and small children, particularly when visiting friends and relatives, vaccination against rotavirus infections will also be important in international travel...
  3. ncbi A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study
    Ursula Wiedermann
    Institute of Specific Prophylaxis and Tropical Medicine, Medical University of Vienna, Kinderspitalgasse 15, 1090 Vienna, Austria
    Breast Cancer Res Treat 119:673-83. 2010
    ..The induction of anti-Her-2-specific antibodies could result in clinical benefit comparable to passive anti-Her-2 antibody therapy...
  4. ncbi Prophylaxis and therapy of allergy by mucosal tolerance induction with recombinant allergens or allergen constructs
    Ursula Wiedermann
    Department of Specific Prophylaxis and Tropical Medicine at the Center for Physiology and Pathophysiology, Medical University of Vienna, Vienna, Austria
    Curr Drug Targets Inflamm Allergy 4:577-83. 2005
    ..That the concept of mucosal tolerance induction/mucosal vaccine delivery may in principal also function in humans is supported by recent clinical trials with locally (sublingual) applied immunotherapy...
  5. ncbi [Adjuvants and additives in vaccines--medical relevance]
    Ursula Wiedermann-Schmidt
    Institut für Spezifische Prophylaxe und Tropenmedizin, Zentrum für Physiologie und Pathophysiologie, Medizinische Universität Wien, Wien, Austria
    Wien Klin Wochenschr 117:510-9. 2005
    ..In these cases risk of morbidity and mortality from the vaccine-preventable diseases outweigh by far any theoretical risk from ethylmercury...
  6. ncbi Tick borne encephalitis TBE--vaccination in non-endemic countries
    Ursula Wiedermann
    Institute of Specific Prophylaxis and Tropical Medicine, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Kinderspitalgasse 15, A 1090 Vienna, Austria
    Travel Med Infect Dis 8:251-6. 2010
    ..Recommendation for travellers to endemic countries and suggestions to extra-European travellers and health authorities as well as vaccination advices are summarized in this paper...
  7. ncbi Vaccination with a human high molecular weight melanoma-associated antigen mimotope induces a humoral response inhibiting melanoma cell growth in vitro
    Stefan Wagner
    Bio Life Science, Vienna, Austria
    J Immunol 174:976-82. 2005
    ..Our results indicate a possible application of this mimotope vaccine as a novel immunotherapeutic agent for the treatment of malignant melanoma...
  8. ncbi Delayed tumor onset and reduced tumor growth progression after immunization with a Her-2/neu multi-peptide vaccine and IL-12 in c-neu transgenic mice
    Stefan Wagner
    Department of Pathophysiology, Center for Physiology and Pathophysiology, Medical University of Vienna, Vienna, Austria
    Breast Cancer Res Treat 106:29-38. 2007
    ..Our findings clearly demonstrate that this multi-peptide vaccine is effective in tumor prevention and support its use against minimal disease, drug-resistant tumors or even for prophylaxis against cancers overexpressing Her-2/neu...
  9. ncbi A hybrid molecule resembling the epitope spectrum of grass pollen for allergy vaccination
    Birgit Linhart
    Cenetr of Physiology and Pathophysiology, Department of Pathophysiology, Medical University of Vienna, Austria
    J Allergy Clin Immunol 115:1010-6. 2005
    ..CONCLUSION: We demonstrate for grass pollen allergy that recombinant hybrid molecules covering the spectrum of the disease-eliciting epitopes of complex allergen sources can be engineered...
  10. ncbi Epitope-specific antibody response to Mel-CAM induced by mimotope immunization
    Christine Hafner
    Department of Dermatology, Division of General Dermatology, Medical University of Vienna, Austria
    J Invest Dermatol 124:125-31. 2005
    ..Our results suggest that mimotopes potentially represent a novel vaccine approach to induce a tumor antigen-specific humoral and cellular response...
  11. ncbi Use of a genetic cholera toxin B subunit/allergen fusion molecule as mucosal delivery system with immunosuppressive activity against Th2 immune responses
    Merima Bublin
    Department of Pathophysiology, Center for Physiology, Pathophysiology and Immunology, Medical University of Vienna, Vienna, Austria
    Vaccine 25:8395-404. 2007
    ....
  12. ncbi Immunoregulation by Toxoplasma gondii infection prevents allergic immune responses in mice
    Angelika Wagner
    Department of Specific Prophylaxis and Tropical Medicine, Center for Physiology, Pathophysiology and Immunology, Medical University of Vienna, Vienna, Austria
    Int J Parasitol 39:465-72. 2009
    ..gondii infection. Our data demonstrate that T. gondii exhibits strong immunomodulating properties which lead to prevention of allergic immune responses and thereby support the hygiene hypothesis...
  13. ncbi Reduction of human melanoma tumor growth in severe combined immunodeficient mice by passive transfer of antibodies induced by a high molecular weight melanoma-associated antigen mimotope vaccine
    Stefan Wagner
    Department of Pathophysiology, Center for Physiology and Pathophysiology, Medical University of Vienna, Vienna, Austria
    Clin Cancer Res 14:8178-83. 2008
    ..2+ that was able to induce anti-HMW-MAA antibodies with antitumor activity in vitro. Here, we investigated the antitumor activity of these antibodies in a human melanoma xenotransplant severe combined immunodeficient (SCID) mouse model...
  14. ncbi [Examples for vaccines against diarrheal diseases--rotavirus and traveller's diarrhea]
    Herwig Kollaritsch
    Institut für Spezifische Prophylaxe und Tropenmedizin, Zentrum für Physiologie und Pathophysiologie, Medizinische Universität Wien, Kinderspitalgasse 15, Vienna, Austria
    Wien Med Wochenschr 157:102-6. 2007
    ..Both vaccines display 85-98% efficacy against severe rotavirus disease and an excellent tolerability with no difference in side reactions to the placebo controls, particularly with respect to intussusceptions...
  15. ncbi Correlation between humoral and cellular immune responses and the expression of the hepatitis A receptor HAVcr-1 on T cells after hepatitis A re-vaccination in high and low-responder vaccinees
    Erika Garner-Spitzer
    Department of Specific Prophylaxis and Tropical Medicine, Center for Physiology, Pathophysiology and Immunology, Medical University of Vienna, Vienna, Austria
    Vaccine 27:197-204. 2009
    ....
  16. ncbi Intranasal tolerance induction with polypeptides derived from 3 noncross-reactive major aeroallergens prevents allergic polysensitization in mice
    Karin Hufnagl
    Department of Specific Prophylaxis and Tropical Medicine, Center for Physiology and Pathophysiology, Medical University of Vienna, Vienna, Austria
    J Allergy Clin Immunol 116:370-6. 2005
    ..Thus, mucosal coapplication of selected peptides/hybrid peptides could be the basis of a mucosal polyvalent vaccine to prevent multiple sensitivities in atopic patients...
  17. ncbi Booster vaccinations against tick-borne encephalitis: 6 years follow-up indicates long-term protection
    Maria Paulke-Korinek
    Department of Specific Prophylaxis and Tropical Medicine, Center for Physiology, Pathophysiology and Immunology, Medical University of Vienna, Kinderspitalgasse 15, A 1090 Vienna, Austria
    Vaccine 27:7027-30. 2009
    ..Therefore, recommendations on booster intervals in TBE endemic areas should be adapted by weighting the risk of infection against the risk of short-lived immunity...
  18. ncbi Susceptibility to nasal and oral tolerance induction to the major birch pollen allergen Bet v 1 is not dependent on the presence of the microflora
    Andreas Repa
    Department of Specific Prophylaxis and Tropical Medicine, Center for Physiology, Pathophysiology and Immunology, Medical University of Vienna, Kinderspitalgasse 15, A 1090 Vienna, Austria
    Immunol Lett 117:50-6. 2008
    ..Our findings may challenge the view that the commensal microflora is a key factor for breakdown of physiological tolerance and allergy development...
  19. ncbi Suppression of human melanoma tumor growth in SCID mice by a human high molecular weight-melanoma associated antigen (HMW-MAA) specific monoclonal antibody
    Christine Hafner
    Department of Dermatology, Division of General Dermatology, Medical University of Vienna, Vienna, Austria
    Int J Cancer 114:426-32. 2005
    ..28S. Our results suggest that anti-HMW-MAA mAbs may represent useful reagents to apply passive immunotherapy to patients with malignant melanoma...
  20. ncbi Inhibition of tumor cell growth by antibodies induced after vaccination with peptides derived from the extracellular domain of Her-2/neu
    Joanna Jasinska
    BioLife Science GmbH, Vienna, Austria
    Int J Cancer 107:976-83. 2003
    ..We conclude from our data that immunization with Her-2/neu peptides successfully induced humoral immune response with anti-tumor activity in an animal model...
  21. ncbi Pretravel consultation: rapid dipstick test as a decision guidance for the application of tetanus booster vaccinations
    Maria Paulke-Korinek
    Department of Specific Prophylaxis and Tropical Medicine, Center for Physiology, Pathophysiology and Immunology, Medical University of Vienna, Vienna, Austria
    J Travel Med 15:437-41. 2008
    ..This immunochromatographic dipstick test yields a positive or negative result...
  22. ncbi Expression of the B subunit of the heat-labile enterotoxin of Escherichia coli in tobacco mosaic virus-infected Nicotiana benthamiana plants and its characterization as mucosal immunogen and adjuvant
    Birgit Wagner
    Department of Pathophysiology, Medical University of Vienna, General Hospital Vienna EBO 3.Q, Waehringer Guertel 18-20, A-1090 Vienna, Austria
    J Immunol Methods 287:203-15. 2004
    ..In conclusion, these results indicate that the plant viral expression system is suitable for the rapid large-scale production of biologically active LTB with strong mucosal adjuvant capacity...
  23. ncbi Lactic acid bacteria as novel adjuvant systems for prevention and treatment of atopic diseases
    Irma Schabussova
    Department of Specific Prophylaxis and Tropical Medicine, Center for Physiology, Pathophysiology and Immunology, Medical University Vienna, Vienna, Austria
    Curr Opin Allergy Clin Immunol 8:557-64. 2008
    ..In this respect, lactic acid bacteria have received increasing attention as potential treatment tools against allergy. In this review, different treatment strategies with probiotics will be discussed in light of the recent literature...
  24. ncbi Persistence of antibodies in 4-8 year old Austrian children after vaccination with hexavalent DTaP-HBV-IPV/Hib and MMR vaccines
    Maria Paulke-Korinek
    Department of Specific Prophylaxis and Tropical Medicine, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Kinderspitalgasse 15, Vienna, Austria
    Vaccine 29:5130-6. 2011
    ..The low levels of antibodies 1-7 years after vaccination against pertussis, rubella and mumps after only one vaccination should be considered when recommending new vaccination schedules...
  25. ncbi Distinctive anti-allergy properties of two probiotic bacterial strains in a mouse model of allergic poly-sensitization
    Irma Schabussova
    Institute of Specific Prophylaxis and Tropical Medicine, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Kinderspitalgasse 15, A 1090 Vienna, Austria
    Vaccine 29:1981-90. 2011
    ..Furthermore, this is the first demonstration of anti-allergic effects of probiotic bacteria in poly-sensitized mice...
  26. ncbi Travellers' diarrhoea - pros and cons of different prophylactic measures
    Angelika Wagner
    Institute of Specific Prophylaxis and Tropical Medicine, Medical University Vienna, Vienna, Austria
    Wien Klin Wochenschr 121:13-8. 2009
    ..The effectiveness but also the relevance of hygiene education, vaccination and antibiotic or probiotic application will be discussed in the context of the travellers' different risk profiles...
  27. ncbi Tetanus immunity in neonates in a developed country
    Andrea Romana Prusa
    Department of Pediatrics and Adolescent Medicine, Division of Paediatric Neonatology, Intensive Care and Neuropaediatry, Medical University of Vienna, Vienna, Austria
    Neonatology 100:52-6. 2011
    ..Our study evaluated seroprotection against tetanus among newborns in Austria, who may gain passive immunity by transplacental transfer of maternal tetanus antibody...
  28. ncbi Antibody persistence following booster vaccination against tick-borne encephalitis: 3-year post-booster follow-up
    Pamela Rendi-Wagner
    Department of Specific Prophylaxis and Tropical Medicine, Medical University Vienna, Austria
    Vaccine 25:5097-101. 2007
    ....
  29. ncbi Persistence of seroprotection 10 years after primary hepatitis A vaccination in an unselected study population
    Pamela Rendi Wagner
    Department of Specific Prophylaxis and Tropical Medicine, Center for Physiology and Pathophysiology, Medical University Vienna, Vienna, Austria
    Vaccine 25:927-31. 2007
    ..001). The only parameter predicting a titer below 10 mIU/ml 10 years after vaccination was the body mass index (p=0.001). This study confirms that protection following primary hepatitis A vaccination persists for more than 10 years...
  30. ncbi Active hospital-based surveillance of rotavirus diarrhea in Austrian children, period 1997 to 2003
    Pamela Rendi-Wagner
    Department of Specific Prophylaxis and Tropical Medicine, Center for Physiology and Pathophysiology, Medical University Vienna, and St Anna Kinderspital, Austria
    Wien Klin Wochenschr 118:280-5. 2006
    ..The aim of this study was to provide data on hospitalization of young children with rotavirus infection in Austria...
  31. ncbi Generation of an allergy vaccine by disruption of the three-dimensional structure of the cross-reactive calcium-binding allergen, Phl p 7
    Kerstin Westritschnig
    Department of Pathophysiology, Vienna General Hospital, AKH, Medical University of Vienna, Vienna, Austria
    J Immunol 172:5684-92. 2004
    ....
  32. ncbi High-affinity IgE receptors on dendritic cells exacerbate Th2-dependent inflammation
    Eva Sallmann
    Division of Immunology, Allergy and Infectious Diseases, Department of Dermatology, Medical University of Vienna, Vienna 1090, Austria
    J Immunol 187:164-71. 2011
    ..Thus, Fc?RI on DCs drives the cascade of pathogenic reactions linking the initial allergen capture by IgE with subsequent Th2-dominated T cell responses and the development of late-phase allergic tissue inflammation...
  33. ncbi Mucosal immunity--mucosal tolerance. A strategy for treatment of allergic diseases
    Ursula Wiedermann
    Department of Pathophysiology, University of Vienna, Vienna, Austria
    Chem Immunol Allergy 82:11-24. 2003
    ..Based on the physiological situation to prevent hypersensitivity reactions, tolerance induction via the mucosa has been proposed as a treatment strategy against human inflammatory diseases, such as allergies...
  34. ncbi [Medical clearance for missions abroad (EEU): definitions, recommendations for use and performance]
    Herwig Kollaritsch
    Institut für Spezifische Prophylaxe und Tropenmedizin, Zentrum für Physiologie und Pathophysiologie, Medizinuniversität Wien, Wien, Osterreich
    Wien Klin Wochenschr 119:13-25. 2007
    ..Additionally, results of this type of medical clearance are defined and prophylactic aspects in terms of pre-travel advice are mentioned...
  35. ncbi Tick-borne encephalitis: new paradigms in a changing vaccination environment
    Ursula Kunze
    Center for Public Health, Institute for Social Medicine, Medical University of Vienna, Rooseveltplatz 3, Vienna, Austria
    Wien Med Wochenschr 161:361-4. 2011
    ..The ISW TBE is part of this complex system, and because the world keeps changing--so should the strategies...
  36. ncbi Humoral immune response against proteophosphoglycan surface antigens of Entamoeba histolytica elicited by immunization with synthetic mimotope peptides
    Helen Melzer
    Division of Specific Prophylaxis and Tropical Medicine, Department of Pathophysiology, University of Vienna, 1090 Vienna, Austria
    FEMS Immunol Med Microbiol 37:179-83. 2003
    ..histolytica PPGs. Our results demonstrate that the KLH-conjugated peptides are able to mimic the EH5 epitope without the M13 phage sequences flanking the peptide inserts and independent of the structural framework of the phage...
  37. ncbi [The Club of Female Professors of the Medical University Vienna]
    Veronika Fialka-Moser
    Der Club der Professorinnen, Wien, Austria
    Wien Med Wochenschr 159:95-109. 2009
    ..This important goal is pursued by continuous interaction with rectorate, academic senate and politicians...